LU88294I2 - Pergolide et ses sels pharmaceutiquement acceptable - Google Patents

Pergolide et ses sels pharmaceutiquement acceptable

Info

Publication number
LU88294I2
LU88294I2 LU88294C LU88294C LU88294I2 LU 88294 I2 LU88294 I2 LU 88294I2 LU 88294 C LU88294 C LU 88294C LU 88294 C LU88294 C LU 88294C LU 88294 I2 LU88294 I2 LU 88294I2
Authority
LU
Luxembourg
Prior art keywords
pergolide
pharmaceutically acceptable
acceptable salts
salts
pharmaceutically
Prior art date
Application number
LU88294C
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU88294I2 publication Critical patent/LU88294I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU88294C 1978-02-08 1993-06-09 Pergolide et ses sels pharmaceutiquement acceptable LU88294I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/875,978 US4166182A (en) 1978-02-08 1978-02-08 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Publications (1)

Publication Number Publication Date
LU88294I2 true LU88294I2 (fr) 1994-05-04

Family

ID=25366703

Family Applications (2)

Application Number Title Priority Date Filing Date
LU80886A LU80886A1 (fr) 1978-02-08 1979-02-06 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes,et leur utilisation therapeutique
LU88294C LU88294I2 (fr) 1978-02-08 1993-06-09 Pergolide et ses sels pharmaceutiquement acceptable

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LU80886A LU80886A1 (fr) 1978-02-08 1979-02-06 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes,et leur utilisation therapeutique

Country Status (36)

Country Link
US (1) US4166182A (fr)
EP (1) EP0003667B1 (fr)
JP (1) JPS54115400A (fr)
AR (1) AR228341A1 (fr)
AT (1) AT371817B (fr)
AU (1) AU523172B2 (fr)
BE (1) BE873883A (fr)
BG (1) BG30474A3 (fr)
CA (1) CA1114368A (fr)
CH (1) CH639088A5 (fr)
CS (1) CS203951B2 (fr)
DD (1) DD141928A5 (fr)
DE (2) DE19375112I2 (fr)
DK (1) DK147362C (fr)
EG (1) EG14076A (fr)
ES (1) ES477547A1 (fr)
FI (1) FI65777C (fr)
FR (1) FR2416891A1 (fr)
GB (1) GB2014140B (fr)
GR (1) GR72776B (fr)
HU (1) HU179970B (fr)
IE (1) IE47827B1 (fr)
IL (1) IL56581A (fr)
LU (2) LU80886A1 (fr)
MX (2) MX5995E (fr)
MY (1) MY8500597A (fr)
NL (1) NL930106I2 (fr)
NZ (1) NZ189561A (fr)
PH (1) PH14903A (fr)
PL (3) PL120849B1 (fr)
PT (1) PT69172B (fr)
RO (3) RO76889A (fr)
SU (1) SU912045A3 (fr)
UA (1) UA6082A1 (fr)
YU (1) YU28279A (fr)
ZA (1) ZA79453B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246265A (en) * 1979-10-01 1981-01-20 Eli Lilly And Company 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
US4563461A (en) * 1983-03-10 1986-01-07 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4551529A (en) * 1983-10-06 1985-11-05 Warner-Lambert Company Guanine-N7 -oxide
DE3340025C2 (de) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof
US4683313A (en) * 1985-06-24 1987-07-28 Eli Lilly And Company 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles
US4782152A (en) * 1985-08-16 1988-11-01 Eli Lilly And Company Decyanation of pergolide intermediate
US4772709A (en) * 1985-10-01 1988-09-20 Eli Lilly And Company Process of making ketoalkanol esters of dihydrolysergic acid
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
DE3868866D1 (de) * 1987-11-20 1992-04-09 Erba Carlo Spa Ergolinderivate mit antiparkinsonwirkung.
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
US5114948A (en) * 1989-10-19 1992-05-19 Eli Lilly And Company Stabilized pergolide compositions
DE3938701A1 (de) * 1989-11-20 1991-05-23 Schering Ag Neue agroclavin- und elymoclavin-derivate, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5063234A (en) * 1990-05-25 1991-11-05 Eli Lilly And Company Method of inhibiting demineralization of bone
EP0641565B1 (fr) * 1990-09-28 2000-03-15 I.F.L.O. S.a.s. di Giorgio e Aldo Laguzzi Médicament contraceptif et régulateur du cycle menstruel, ayant des proprietés oncostatiques
US5416090A (en) * 1991-01-31 1995-05-16 Eli Lilly And Company Method of treating inflammation
US5463060A (en) 1992-05-21 1995-10-31 Eli Lilly And Company One-pot process
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
IT1307934B1 (it) * 1999-01-27 2001-11-29 Poli Ind Chimica Spa Processo per la preparazione di derivati alchimercaptometilergolinici.
AU2635599A (en) * 1999-03-17 2000-10-04 Eugen Eigenmann Use of prolactin inhibitors for the treatment of fertility problems in animal species
US6548484B1 (en) 2000-04-12 2003-04-15 International Medical Innovations, Inc. Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
US6388079B1 (en) 2000-08-29 2002-05-14 Scinopharm Singapore Pte Ltd. Process for preparing pergolide
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
CN101481405A (zh) * 2001-06-08 2009-07-15 研究及应用科学协会股份有限公司 生长激素释放抑制因子-多巴胺嵌合类似物
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
WO2003078432A2 (fr) * 2002-03-15 2003-09-25 Antibioticos S.P.A. Procede de synthese de pergolide
GB0409785D0 (en) 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
GB0505965D0 (en) 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
US7939665B2 (en) * 2007-05-04 2011-05-10 Apotex Pharmachem Inc. Efficient process for the preparation of cabergoline and its intermediates
EP2113504A1 (fr) * 2008-04-29 2009-11-04 LEK Pharmaceuticals D.D. Préparation d'esters alkyliques de l'acide N-6 déméthylé, 9,10-dihydrolysergique
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
CN104768565B (zh) 2012-11-01 2017-04-26 益普生制药股份有限公司 促生长素抑制素类似物及其二聚体
US9585885B2 (en) 2012-12-10 2017-03-07 Kissei Pharmaceutical Co., Ltd. Substituted pyrido[2,3-g]quinazolines as dopamine D2 receptor agonists
DK3197429T3 (da) 2014-09-25 2024-08-26 Boehringer Ingelheim Vetmedica Gmbh Kombinationsbehandling med sglt2-hæmmere og dopaminagonister til forebyggelse af metaboliske lidelser af dyr i hestefamilien
CN106866656A (zh) * 2017-02-28 2017-06-20 西南交通大学 一类麦角碱衍生物及其在预防和治疗精神疾病的用途
US20190374534A1 (en) 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
AR206772A1 (es) * 1972-07-21 1976-08-23 Lilly Co Eli Procedimiento para preparar una nueva d-2-halo-6-metil-8-ciano(carboxamido)metil ergolina
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3985752A (en) * 1974-12-06 1976-10-12 Eli Lilly And Company 6-Methyl-8-(substituted) methylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4054660A (en) * 1975-04-14 1977-10-18 Eli Lilly And Company Method of inhibiting prolactin
JPS5283894A (en) * 1976-01-01 1977-07-13 Lilly Co Eli 88thiomethyl ergoline

Also Published As

Publication number Publication date
ES477547A1 (es) 1980-04-16
PH14903A (en) 1982-01-29
BG30474A3 (bg) 1981-06-15
HU179970B (en) 1983-01-28
EP0003667A1 (fr) 1979-08-22
FI790351A7 (fi) 1979-08-09
CH639088A5 (fr) 1983-10-31
AR228341A1 (es) 1983-02-28
NL930106I2 (nl) 1997-02-03
DK147362C (da) 1988-06-27
US4166182A (en) 1979-08-28
RO76889A (fr) 1981-08-30
AU523172B2 (en) 1982-07-15
FI65777B (fi) 1984-03-30
CA1114368A (fr) 1981-12-15
DE19375112I2 (de) 2003-06-12
AT371817B (de) 1983-08-10
UA6082A1 (uk) 1994-12-29
MX5995E (es) 1984-09-18
IL56581A (en) 1982-05-31
YU28279A (en) 1983-02-28
AU4391779A (en) 1979-08-16
DE2963320D1 (en) 1982-09-02
MX9203107A (es) 1992-07-31
ZA79453B (en) 1980-09-24
MY8500597A (en) 1985-12-31
FI65777C (fi) 1984-07-10
PT69172B (pt) 1992-05-29
SU912045A3 (ru) 1982-03-07
PL120849B1 (en) 1982-03-31
JPS54115400A (en) 1979-09-07
PL124704B1 (en) 1983-02-28
RO81857A (fr) 1983-06-01
DK147362B (da) 1984-07-02
RO81856B (ro) 1983-05-30
EG14076A (en) 1983-12-31
GB2014140B (en) 1982-08-04
PL126313B1 (en) 1983-07-30
GR72776B (fr) 1983-12-05
PL213283A1 (fr) 1980-02-25
CS203951B2 (en) 1981-03-31
FR2416891A1 (fr) 1979-09-07
FR2416891B1 (fr) 1981-10-16
JPS6363544B2 (fr) 1988-12-07
BE873883A (fr) 1979-08-02
PT69172A (en) 1979-03-01
EP0003667B1 (fr) 1982-07-14
IE790232L (en) 1979-08-08
NZ189561A (en) 1981-12-15
DD141928A5 (de) 1980-05-28
RO81856A (fr) 1983-06-01
ATA91479A (de) 1982-12-15
GB2014140A (en) 1979-08-22
RO81857B (ro) 1983-05-30
IE47827B1 (en) 1984-06-27
IL56581A0 (en) 1979-05-31
LU80886A1 (fr) 1979-06-07
DK51379A (da) 1979-09-18
NL930106I1 (nl) 1993-10-18

Similar Documents

Publication Publication Date Title
LU88294I2 (fr) Pergolide et ses sels pharmaceutiquement acceptable
PH17515A (en) Pyridazinone-substituted benzimidazoles and salts thereof
DE2967692D1 (de) Azabicycloalkyl derivatives
GR64905B (en) N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
LU90037I2 (fr) Konakion et ses dérivés pharmaceutiquement acceptables
DK363080A (da) Clavulansyresalte og anvendelse deraf
LU88293I2 (fr) Nizatidine et ses sels pharmaceutiquement
NO150832C (no) Forankrings- og overfoeringsstasjon
FI792634A7 (fi) Pappersprodukt med stor fyllaemneshalt
DK539979A (da) Quinazolinonderivater samt deres fremstilling og anvndelse
FI792348A7 (fi) Formkombination och foerfarande foer kontinuerlig gjutning av metallserier med hoeg hastighet
FI782696A7 (fi) Foerfarande foer paovisande av irritament i blod
DK74979A (da) Invalidestol
FI801842A7 (fi) Polymerer med hoeg rivhaollfasthet
FI56873B (fi) Med formkuggar foersedd valskonstruktion foer avfallskrossanordning avsedd foer avstjaelpningsplatser
SE7800512L (sv) Argininamider och farmaceutiskt godtagbara salter derav
DK469879A (da) Adenosintriphosphatderivat og salte deraf
DK319578A (da) Angiotensinpeptider samt deres fr&mstilling
SE7708943L (sv) Forfarande for halocyaninsalter och steriliserade losningar derav
BE875246A (fr) Agents therapeutiques
GB2027022B (en) Pyridoxine derivatives and their use
FI792381A7 (fi) Anordning foer fyllning av kablar omfattande flera kaernenheter med fluidiserat pulver
TR20965A (tr) Herbisid muameleler ve formuelasyonlar
ZA794581B (en) N 2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
GB1538206A (en) N2-arylsulphonyl-l-argininamides and the pharmaceutically acceptable salts thereof